Jiangxi Hongyuan Pharmaceutical Co., Ltd.
Jiangxi Hongyuan Pharmaceutical Co., Ltd., commonly referred to as Hongyuan Pharma, is a prominent player in the pharmaceutical industry, headquartered in Jiangxi, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Hongyuan Pharma is renowned for its innovative formulations and commitment to research and development. The company’s core offerings include a diverse range of active pharmaceutical ingredients (APIs) and finished dosage forms, distinguished by their efficacy and safety profiles. Recognised for its dedication to quality and compliance with international standards, Jiangxi Hongyuan Pharmaceutical has positioned itself as a trusted supplier in both domestic and global markets, achieving notable milestones in product development and market expansion.
DitchCarbon Score
How does Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s reported carbon emissions
Jiangxi Hongyuan Pharmaceutical Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Jiangxi Hongyuan Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Jiangxi Hongyuan to establish clear climate commitments and reduction initiatives to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jiangxi Hongyuan Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
